The FDA today announced that Medtronic (NYSE:MDT) has expanded the Class I recall of its MiniMed 600 series insulin pumps. Medtronic today notified customers by email and phone that the recall has been expanded to replace all MiniMed 600 series insulin pumps that contain the clear container ring. The Fridley, Minnesota-based company first warned of safety problems with the […]
MiniMed
Medtronic warns patients of MiniMed insulin pump safety issue
Medtronic (NYSE:MDT) is warning patients who use its MiniMed 600 series insulin pumps of an issue that could cause a dangerous over- or under-dosing of insulin. In a letter to patients, the company said that the pump’s insulin reservoir may become loose if a retainer ring breaks, preventing a proper lock. Dropping the pump or […]
Medtronic launches MiniMed 630G in U.S.
Medtronic (NYSE:MDT) announced the U.S. launch of the MiniMed 630G insulin management system it developed to work with a blood glucose meter made by Ascensia Diabetes Care. The MiniMed 630G uses Medtronic’s SmartGuard software and a continuous glucose monitor to warn patients when glucose levels reach a preset low and to cease insulin delivery if the user doesn’t […]
Medtronic touts insulin pump study
Patients with Type II diabetes fared better with Medtronic‘s (NYSE:MDT)MiniMed Paradigm Veo insulin pumps that with multiple daily injections, according to a Medtronic-backed study published in the journal Diabetes, Obesity & Metabolism. Fridley, Minn.-based Medtronic said the 331-patient Opt2mise clinical trial compared the MDI cohort with the MiniMed-treated group; after 6 months, the MDI cohort was moved to the […]